<p>Fonterra announced Wednesday that its 50-50 joint venture with Royal FrieslandCampina, DMV-Fonterra Excipients (DFE), had agreed to acquire ingredient manufacturer Brahmar Cellulose Private Limited (BCPL), based in Cuddalore, Tamil Nadu, reported Xinhua. <br /><br />BCPL manufactures ingredients used by the pharmaceutical industry to make tablets and pills. <br /><br />DFE was already the world's leading supplier of lactose excipients -- substances used to bind or carry the active ingredients in tablets, capsules and powders for medical inhalers -- accounting for around half of the global sales and for 5 percent to 10 percent of oral tablet excipients, said a statement from Fonterra. <br /><br />The acquisition would join two companies that developed, produced and marketed excipients and would help reduce supply chain and formulation costs, said the statement. <br />DFE chief executive Jan Jongsma said it would create a unique market position for DFE as a manufacturer and supplier of all the most commonly used ingredients in the pharmaceutical industry. <br /><br />"Long-term synergies will be achieved by combining DFE's current global market position and sales network with Brahmar Cellulose extensive product knowledge and market position in India," said Jongsma. <br /><br />"The acquisition of Brahmar Cellulose is a further step in achieving our ambition to become a leading supplier in pharmaceutical excipients and will give a stronger base for future developments in this area." <br /><br />The acquisition would be completed in the fourth quarter this year subject to conditions, including the obtaining of regulatory consents.<br /><br />New Zealand-based Fonterra, a farmer-owned cooperative, is the largest processor of milk in the world, producing more than 2 million tonnes of dairy products every year and employing 16,000 staff.</p>
<p>Fonterra announced Wednesday that its 50-50 joint venture with Royal FrieslandCampina, DMV-Fonterra Excipients (DFE), had agreed to acquire ingredient manufacturer Brahmar Cellulose Private Limited (BCPL), based in Cuddalore, Tamil Nadu, reported Xinhua. <br /><br />BCPL manufactures ingredients used by the pharmaceutical industry to make tablets and pills. <br /><br />DFE was already the world's leading supplier of lactose excipients -- substances used to bind or carry the active ingredients in tablets, capsules and powders for medical inhalers -- accounting for around half of the global sales and for 5 percent to 10 percent of oral tablet excipients, said a statement from Fonterra. <br /><br />The acquisition would join two companies that developed, produced and marketed excipients and would help reduce supply chain and formulation costs, said the statement. <br />DFE chief executive Jan Jongsma said it would create a unique market position for DFE as a manufacturer and supplier of all the most commonly used ingredients in the pharmaceutical industry. <br /><br />"Long-term synergies will be achieved by combining DFE's current global market position and sales network with Brahmar Cellulose extensive product knowledge and market position in India," said Jongsma. <br /><br />"The acquisition of Brahmar Cellulose is a further step in achieving our ambition to become a leading supplier in pharmaceutical excipients and will give a stronger base for future developments in this area." <br /><br />The acquisition would be completed in the fourth quarter this year subject to conditions, including the obtaining of regulatory consents.<br /><br />New Zealand-based Fonterra, a farmer-owned cooperative, is the largest processor of milk in the world, producing more than 2 million tonnes of dairy products every year and employing 16,000 staff.</p>